Skip to main content
TipRanks
Go Ultimate75% OFF

Kevin Mcelwee Insider Profile

4 Followers

Kevin Mcelwee, Chief Scientific Officer at RepliCel Life Sciences, holds 3.66M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Kevin Mcelwee Bought 670,833 shares of RepliCel Life Sciences on Jan 19, 2023 for an estimated value of $60.37K.

Kevin Mcelwee's Trading History

REPCF
RepliCel Life Sciences
Jan 19, 2023Chief Scientific OfficerInformative Buy60.37K―
REPCF
Insider Shares: 3.66M (715.70%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 19, 2023Informative BuyC$60.37K670,833C$0.09-40.00%―
Jun 04, 2021Informative BuyC$18.37K47,727C$0.38-72.10%―
Aug 21, 2020Informative BuyC$23.63K131,250C$0.18+60.70%―
Jan 19, 2019Informative BuyC$26.25K55,263C$0.48-23.30%―
Feb 28, 2012Uninformative BuyC$0.00385,611C$0.00――

You May Also Like

Kevin Mcelwee insider profile FAQ

What is the percentage of profitable transactions made by Kevin Mcelwee?
The percentage of profitable transactions made by Kevin Mcelwee is 25%.
What is the average return per transaction made by Kevin Mcelwee?
The average return per transaction made by Kevin Mcelwee is -18.60%.
What stocks does Kevin Mcelwee hold?
Kevin Mcelwee holds: REPCF stocks.
What was Kevin Mcelwee’s latest transaction?
Kevin Mcelwee’s latest transaction was an Informative Buy of $60.37K.
What was Kevin Mcelwee's most profitable transaction?
Kevin Mcelwee’s most profitable transaction was an Informative Buy of REPCF stock on August 21, 2020. The return on the trade was 60.70%.
What is Kevin Mcelwee's role in RepliCel Life Sciences?
Kevin Mcelwee's role in RepliCel Life Sciences is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.